This registry aims to collect informations about patients with endocrine tumors (Thyroid, Parathyroid, Adrenal, Endocrine Pancreas, Endocrine Digestive Tube) who undergo endocrine surgical procedures. This registry is part of the Eurocrine Project.
The EUROCRINE project aims to decrease morbidity and mortality of rare endocrine tumours, by means of a pan-European database. Recording and accessing data at the European level, makes it possible to identify these tumours, which cannot be distinguished at local or national level, because of their extreme rarity. Dissemination of results aims to raise clinical standards and reduce differences in practise between clinics and member states, and thereby diminish morbidity and mortality. Comparison of practice and outcomes will be especially interesting for centres wanting to improve their standards to what is currently considered best practice. EUROCRINE will be a key means by which the medical profession, researchers, health policy makers, and not least patients, can benefit from an increase in knowledge related to diagnosis, treatment, and future clinical research in the field of rare endocrine tumours.
Study Type
OBSERVATIONAL
Enrollment
3,000
CHU Nancy
Vandœuvre-lès-Nancy, France
RECRUITINGPostoperative complications (endocrine surgical procedure)
morbidity rate in percentage (%)
Time frame: 12 months after surgical procedure
Postoperative complications severity (endocrine surgical procedure)
Dindo-Clavien classification in percentage (%)
Time frame: 12 months after surgical procedure
Postoperative mortality (endocrine surgical procedure)
mortality rate in percentage (%)
Time frame: 12 months after surgical procedure
CT imaging before endocrine surgical procedure (Tumor characteristics)
Density in Hounsfield unit (HU)
Time frame: Baseline
CT imaging before endocrine surgical procedure (Coronary artery score)
CAC score in Agatston score unit (HU)
Time frame: Baseline
CT imaging before endocrine surgical procedure (Sarcopenia)
Evaluation of sarcopenia using L3 skeletal muscle index (in cm²/m²)
Time frame: preoperative period
Bone mineral density
dual-energy x-ray absorptiometry (DEXA) (in T-score unit)
Time frame: Baseline
Intraoperative systolic arterial pressure
systolic arterial pressure (in mmHg)
Time frame: Intraoperative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Intraoperative diastolic arterial pressure
diastolic arterial pressure (in mmHg)
Time frame: Intraoperative
Parathormone plasma levels
Parathormone (in pg/mL)
Time frame: Baseline and up to 12 months after surgical procedure
Aldosterone plasma levels
Aldosterone (in pmol/L)
Time frame: Baseline and up to 12 months after surgical procedure
Plasma renin activity
Renin (in μIU/mL)
Time frame: Baseline and up to 12 months after surgical procedure
Plasma free metanephrines
metanephrines (in nmol/L)
Time frame: Baseline and up to 12 months after surgical procedure
PET scanning
standardized uptake values (SUV tumor / SUV liver ratio)
Time frame: Baseline